VEA Among Developed ETFs
End-of-day Nov 18, 2026 · 56 Developed ETFs by YTD
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.1% | −4.6% | −4.4% | −8.2% | +7.8% | +13.1% | +66.2% | +49.1% | +145.6% | +148.0% |
| Peer average | −0.9% | −3.4% | −2.8% | −5.3% | +7.0% | +11.1% | +60.2% | +47.8% | +142.6% | — |
| S&P 500 · VOO | −0.3% | −3.9% | −5.0% | −4.0% | +8.0% | +10.9% | +72.4% | +68.9% | +302.1% | — |
$24 of every $1,000 in VEA is Samsung
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | 005930.KSSamsung Electronics | Technology | 2.37% | $236.85 | 45.4M | $7.42B |
| 2 | ASML.ASAsml | Technology | 1.90% | $190.47 | 3.8M | $5.96B |
| 3 | 000660.KSSK hynix | Technology | 1.83% | $183.11 | 5.6M | $5.73B |
| 4 | —Slbbh1142 | — | 1.11% | $110.80 | 34.7M | $3.47B |
| 5 | ROP.SWRoche AG | Healthcare | 1.08% | $107.85 | 6.9M | $3.38B |
| 6 | SHEL.LShell | Energy | 0.99% | $99.13 | 57.4M | $3.10B |
| 7 | NOVN.SWNovartis AG | Healthcare | 0.94% | $94.38 | 18.3M | $2.96B |
| 8 | HSBA.LHsbc | Financial Services | 0.92% | $92.06 | 168.6M | $2.88B |
| 9 | RY.TORoyal Bank of Canada | Financial Services | 0.89% | $89.25 | 13.7M | $2.79B |
| 10 | AZN.LAstraZeneca | Healthcare | 0.88% | $87.65 | 14.7M | $2.74B |
| 11 | NESN.SWNestle | Consumer Defensive | 0.83% | $82.86 | 25.3M | $2.59B |
| 12 | 8306.TMitsubishi UFJ Financial Group | Financial Services | 0.74% | $73.70 | 106.9M | $2.31B |
| 13 | SAP.DESAP SE | Technology | 0.72% | $72.08 | 9.6M | $2.26B |
| 14 | SIE.DESiemens AG | Industrials | 0.67% | $67.23 | 7.1M | $2.11B |
| 15 | TD.TOToronto-Dominion Bank/The | Financial Services | 0.64% | $64.36 | 16.2M | $2.02B |
of the $687B in 67 Developed ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | 005930.KS | Samsung Electronics | 2.37% |
| 2 | ASML.AS | Asml | 1.90% |
| 3 | 000660.KS | SK hynix | 1.83% |
| 4 | ROP.SW | Roche AG | 1.08% |
| 5 | SHEL.L | Shell | 0.99% |
| 6 | NOVN.SW | Novartis AG | 0.94% |
| 7 | HSBA.L | Hsbc | 0.92% |
| 8 | RY.TO | Royal Bank of Canada | 0.89% |
| 9 | AZN.L | AstraZeneca | 0.88% |
| 10 | NESN.SW | Nestle | 0.83% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 18, 2026 | Sep 22, 2026 | $0.18 |
| Jun 18, 2026 | Jun 23, 2026 | $0.38 |
| Mar 20, 2026 | Mar 24, 2026 | $0.11 |
| Dec 19, 2025 | Dec 23, 2025 | $1.04 |
| Sep 19, 2025 | Sep 23, 2025 | $0.29 |
| Jun 20, 2025 | Jun 24, 2025 | $0.44 |
| Mar 21, 2025 | Mar 25, 2025 | $0.24 |
| Dec 20, 2024 | Dec 24, 2024 | $0.71 |
| Sep 20, 2024 | Sep 24, 2024 | $0.14 |
| Jun 21, 2024 | Jun 25, 2024 | $0.46 |
| Mar 15, 2024 | Mar 20, 2024 | $0.29 |
| Dec 18, 2023 | Dec 21, 2023 | $0.61 |